The real problem holding back connected vehicle programmes

Tern plc

Automakers are pushing hard to deliver software-defined vehicles with full over-the-air functionality. But many programmes are hitting delays and complications that have little to do with software quality or hardware design. The problem is identity, specifically, how manufacturers handle cryptographic keys, certificates, and trust across every electronic component and software process in the vehicle.

This used to be a security issue. Now, it is a production and operations issue, directly affecting rollout speed, servicing, and regulatory compliance. As vehicles become more connected and updates more frequent, identity management is turning into a core constraint that affects timelines and scale. Automotive platforms are struggling to keep cryptographic assets consistent across multiple suppliers, regions, and ECU generations. That inconsistency can block updates, break rollback mechanisms, and prevent legitimate servicing.

The UN’s WP.29 cybersecurity requirements, together with ISO 21434 and upcoming legislation like the EU Cyber Resilience Act, are putting formal pressure on OEMs to prove their vehicles are secure, traceable, and tamper-proof throughout their lifetime. Even authorised servicing now demands stricter identity and access control, forcing manufacturers to rework how they handle keys and certificates from factory to workshop.

Device Authority is one such company helping OEMs manage identity at scale. Its platform supports automated certificate provisioning, policy enforcement, and compliance tracking across ECUs, software components and servicing tools.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Search